Blood cancers, Myelodysplastic syndrome (MDS)
Results
Phase 2
This study was to see how well a new injection called romiplostim worked to improve platelet counts in people with myelodysplastic syndrome (MDS).
Recruitment start: 1 March 2009
Recruitment end: 19 November 2010
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Prof David Bowen
Amgen
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 15 Feb 2016
CRUK internal database number: 4554
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
